|
1st International Conference on Steroid Hormones and Receptors
Date(s):
October 16 — 18, 2024
Venue:University of New Mexico Comprehensive Cancer Center
1201 Camino DE Salud NE
Albuquerque, NM 87102-4517
Website:Not available
Fee(s):This event has a fee
Description:The SHR conferences will explore state-of-the-art advances in steroid hormone and receptor functions, both rapid and genomic, in various aspects of biology and medicine in terms of normal physiology and pathophysiology....
Find it on Map
University of New Mexico Comprehensive Cancer Center
|
Sessions information is not available at this time.
|
|
Track information is not available at this time.
|
|
Alvarez de la Rosa, Diego
Brown, Kristy A
Organization: University of Kansas Medical Center
Bruder do Nascimento, Thiago
Organization: University of Pittsburgh School of Medicine
Calvo, Noelia
Organization: University of Toronto
Massimiliano Caprio is Professor of Endocrinology at San Raffaele Roma University. He is the head of the Laboratories of Cardiovascular Endocrinology at the Research Center of IRCCS San Raffaele Pisana in Rome, and works as a consultant endocrinologist and diabetologist . He has an internationally recognized expertise in the exploration of the roles of mineralocorticoid receptor activation in obe
Conzen, Suzanne D
Organization: UT Southwestern Medical Center
Fanning, Sean William
Organization: Loyola University
Gertz, Jay
Organization: University of Utah
Gorelick, Daniel Aaron
Organization: Baylor College of Medicine
Kojetin, Douglas
Organization: Vanderbilt University
Leslie, Kimberly K
Organization: University of New Mexico
Role of novel estrogens in preventing menopause associated obesity and metabolic syndrome
McDonnell, Donald Patrick
Organization: Duke University School of Medicine
Ostrander, Julie Hanson
Organization: University of Minnesota
Dr. Jennifer Richer, Professor with tenure, Department of Pathology, University of Colorado Anschutz Medical Campus, has studied steroid hormone receptor action in breast for over 25 years. Translational studies from her lab led to two completed clinical trials targeting the androgen receptor in primary and metastatic breast cancer. The Richer lab also discovered a mechanism by which carcinomas c
|
|
Sponsor information is not available at this time.
|
|
|
|